Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial - Paulina

Login with Wikimedia

Login with your Wikimedia account to add/edit data Login

Missing/wrong data? Log in to edit

Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.

Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial

scientific article published on 02 July 2018

Author/s

author: Carsten Grüllich, Ulrich Abel

Work details

Publication date

July 2, 2018

Language

English

Copyright status

copyrighted